Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.88)
# 3,186
Out of 5,067 analysts
57
Total ratings
54.05%
Success rate
-3.57%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Overweight | $350 → $360 | $337.53 | +6.66% | 6 | Nov 7, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $142 → $146 | $127.19 | +14.79% | 9 | Oct 16, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $172 → $184 | $190.96 | -3.64% | 5 | Aug 8, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $16.26 | +23.00% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $21.47 | +281.93% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $111.39 | +122.64% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $568.48 | -40.37% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.75 | +99.63% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $1.56 | +1,630.77% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $93.52 | +18.69% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $62.21 | +131.07% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $98.06 | -42.89% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $87.17 | -15.11% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $84.71 | -9.49% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $12.53 | +618.28% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $87.95 | - | 1 | Dec 12, 2019 |
Insulet
Nov 7, 2025
Maintains: Overweight
Price Target: $350 → $360
Current: $337.53
Upside: +6.66%
Abbott Laboratories
Oct 16, 2025
Maintains: Overweight
Price Target: $142 → $146
Current: $127.19
Upside: +14.79%
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $172 → $184
Current: $190.96
Upside: -3.64%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $16.26
Upside: +23.00%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $21.47
Upside: +281.93%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $111.39
Upside: +122.64%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $568.48
Upside: -40.37%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.75
Upside: +99.63%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $1.56
Upside: +1,630.77%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $93.52
Upside: +18.69%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $62.21
Upside: +131.07%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $98.06
Upside: -42.89%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $87.17
Upside: -15.11%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $84.71
Upside: -9.49%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $12.53
Upside: +618.28%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $87.95
Upside: -